Correlation Between Cardio Diagnostics and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Viridian Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Viridian Therapeutics.
Diversification Opportunities for Cardio Diagnostics and Viridian Therapeutics
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cardio and Viridian is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Viridian Therapeutics
Assuming the 90 days horizon Cardio Diagnostics Holdings is expected to under-perform the Viridian Therapeutics. In addition to that, Cardio Diagnostics is 2.23 times more volatile than Viridian Therapeutics. It trades about -0.31 of its total potential returns per unit of risk. Viridian Therapeutics is currently generating about -0.03 per unit of volatility. If you would invest 1,873 in Viridian Therapeutics on October 20, 2024 and sell it today you would lose (60.00) from holding Viridian Therapeutics or give up 3.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. Viridian Therapeutics
Performance |
| Timeline |
| Cardio Diagnostics |
| Viridian Therapeutics |
Cardio Diagnostics and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and Viridian Therapeutics
The main advantage of trading using opposite Cardio Diagnostics and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Cardio Diagnostics vs. Agilent Technologies | Cardio Diagnostics vs. Equillium | Cardio Diagnostics vs. 23Andme Holding Co | Cardio Diagnostics vs. DiaMedica Therapeutics |
| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |